Lifeboat News: The Blog – Safeguarding Humanity

Get the latest international news and world events from around the world.

Oct 27
2026

Implantable device uses ultrasound to improve drug delivery to the brain

Patients with glioblastoma, an aggressive type of brain tumor, usually undergo surgery to remove the tumor. However, it’s difficult for surgeons to remove all of the cancer cells, and the tumor often recurs.

MIT researchers have now designed an implantable drug-delivery device that they hope could help prevent recurrence of glioblastoma. Their device contains a reservoir that can release drugs over an extended period, along with ultrasound transducers that use sound waves to help drugs spread farther through the brain and bypass the blood-brain barrier.

Such a device could be implanted in the brain during surgery, then gradually release drugs that would help kill the remaining tumor cells. After implantation, a wireless controller can be used to program the exact ultrasound dosages to be delivered, enhancing the reach of the delivered therapy.

Oct 27
2026

JWST and ALMA reveal a dusty, rapidly growing black hole in the early universe

A new study reveals a dust-reddened quasar from a time when the universe was less than a billion years old. Located at a redshift of 6.5488, the object J1440+0019 contains a rapidly accreting supermassive black hole with a mass of about 1.1 billion suns. The paper was posted to the arXiv preprint server on Oct. 9.

Cosmic reionization is estimated to have happened roughly between 600 million and a billion years (redshifts 6 to 8) after the Big Bang. This epoch is when ionizing UV radiation from early stars and galaxies converted the universe’s neutral hydrogen gas into the ionized state seen today. Studying quasars and galaxies from this era can put a limit on the redshift at which it occurred.

Most quasars from this period are identified by their bright rest-frame ultraviolet light. This method may fail for quasars with even modest dust reddening—their UV emission may be heavily blocked by the surrounding dust envelope. Previous studies suggest that a large fraction of early active galactic nuclei (AGN) are obscured. Only a handful of reddened quasars are known at redshifts around and beyond 6, and they were found by different methods.

Oct 27
2026

Watch the universe emerge from the dark ages, with Lumina

The computer simulation Lumina is giving scientists a detailed view of how the universe’s earliest galaxies, stars, and other structures could have developed during the first 2 billion years after the Big Bang.

Oct 27
2026

Cancer Drugs’ Serious Side Effects Explained by Missed Discovery

Drugs targeting the protein Wee1 looked promising, but an incomplete understanding of their mechanism likely led to the serious side effects seen in clinical trials.

Oct 27
2026

Immorta Bio’s nine-amino-acid peptide aims at zombie cells

Immorta Bio says its AI-designed SenoMune-0257 prompts T cells to clear senescent cells, and plans first human evaluation before year-end.

Oct 27
2026

CSF DNA testing when brain tumor diagnosis is uncertain

A Mayo Clinic study examines whether DNA in cerebrospinal fluid can provide clues when MRI is unclear or brain tumor biopsy is difficult or unsafe.

Oct 27
2026

Rejuvenation breakthrough: Scientists reverse 60 years of aging in human cells

“We also know that this epigenetic rejuvenation ensures that the cells actually behave like young cells,” says the scientist.

A Slower Rejuvenation Process Reveals New Clues

Scientists have previously observed that reprogramming cells can reset their biological age. However, earlier demonstrations of this effect involved a more complicated process requiring two distinct stages.

Oct 27
2026

CRISPR gene editing: from one patient to a platform

A personalized CRISPR treatment for a critically ill baby shows how editing, RNA manufacturing, and delivery are converging into faster, more reproducible therapeutic workflows.

Oct 26
2026

Dual targeting of transferrin receptor and CD98hc enhances brain exposure of large molecules

Very intriguing paper on antibodies equipped with binding domains for both the TfR1 and CD98hc receptors (found abundantly on the blood-brain-barrier). Brain uptake was enhanced by using binding domains for both receptors. Wells et al. also varied the TfR1/CD98hc affinities of the binding domains and explored how different combinations of affinities influenced brain uptake and localization within the brain. Interestingly, higher CD98hc affinity made the antibody brain concentration peak at 7 days post-injection whereas higher TfR1 affinity made the antibody brain concentration peak at 1 day post-injection. Additionally, stronger CD98hc binding led to more astrocyte localization while stronger TfR1 binding led to more neuronal localization.

Wells et al. developed a dual-targeting transport vehicle binding both transferrin receptor and CD98hc, two proteins highly expressed at the blood-brain barrier. Through affinity tuning, the authors demonstrated that brain concentration, kinetics, and cellular distribution can be modulated, offering a versatile platform for CNS delivery of biotherapeutics.

Oct 26
2026

This startup’s self-driving excavators help dig up $600M in new funding

Bedrock Robotics has raised $600 million in a funding round that values the autonomous vehicle technology startup at $4.1 billion, marking a speedy ascent for the two-year-old company.

The Series C round, co-led by CapitalG and Emergence Capital, comes two months after the startup reached a key milestone: moving its autonomous excavators beyond testing and pilot programs and putting them to work on active construction sites.

Bedrock Robotics has developed a self-driving kit that can be retrofitted onto construction and other worksite vehicles. Excavators outfitted with Bedrock’s autonomous-driving tech are now commercially operating at a Nevada-based water treatment facility, an earthwork site run by Champion Site Prep in Texas_, and a 1.2 million-cubic-yard civil sitework project with Zachry Construction Corporation.